| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/27/2008 | US20080293647 Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer |
| 11/27/2008 | US20080293618 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors |
| 11/27/2008 | US20080293163 Methods to identify compounds that modulate rage |
| 11/27/2008 | US20080293137 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments |
| 11/27/2008 | US20080293116 Ovary-specific genes and proteins |
| 11/27/2008 | US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 11/27/2008 | US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts |
| 11/27/2008 | US20080292729 Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment |
| 11/27/2008 | US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 11/27/2008 | US20080292703 Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical Conjugation, and Their Use in the Pharmaceutical Field |
| 11/27/2008 | US20080292687 Methods of Treating Cancer and Other Conditions or Disease States Using Lfmau and Ldt |
| 11/27/2008 | US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy |
| 11/27/2008 | US20080292637 Therapeutic Uses of A3 Adenosine Receptor Antibodies |
| 11/27/2008 | US20080292631 Treatment with anti-vegf antibodies |
| 11/27/2008 | US20080292626 Kinesin inhibitors |
| 11/27/2008 | US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 11/27/2008 | US20080292616 Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same |
| 11/27/2008 | US20080292614 DNA sequences for human angiogenesis genes |
| 11/27/2008 | US20080292609 Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies |
| 11/27/2008 | US20080292591 localized foci of model tumor cells highly correlated to actual clinical tumor cells; genetic engineering; drug screening |
| 11/27/2008 | US20080292585 Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom |
| 11/27/2008 | US20080292583 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation |
| 11/27/2008 | US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea |
| 11/27/2008 | US20080292553 Phosphoramidate Derivatives of Fau |
| 11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/27/2008 | DE202008012041U1 Vaginalzäpfchen auf Basis von 3,3'-Dindolylmethan (Methindol) Vaginal suppositories based on 3,3'-Dindolylmethan (Methindol) |
| 11/27/2008 | DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis |
| 11/27/2008 | DE102007023614A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula |
| 11/27/2008 | CA2691997A1 Triazolyl aminopyrimidine compounds |
| 11/27/2008 | CA2688823A1 Heterocyclic kinase modulators |
| 11/27/2008 | CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
| 11/27/2008 | CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 11/27/2008 | CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity |
| 11/27/2008 | CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof |
| 11/27/2008 | CA2687474A1 Triazolyl aminopyrimidine compounds |
| 11/27/2008 | CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 11/27/2008 | CA2687247A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 11/27/2008 | CA2687160A1 Spiroindolinone derivatives |
| 11/27/2008 | CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| 11/27/2008 | CA2686675A1 3,3-spiroindolinone derivatives |
| 11/27/2008 | CA2686421A1 P38.alpha. as a therapeutic target in bladder carcinoma |
| 11/27/2008 | CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors |
| 11/27/2008 | CA2685907A1 Method for diagnosis and treatment of pancreatic cancer |
| 11/27/2008 | CA2685049A1 Antibodies useful for therapy and diagnosis of cancer |
| 11/27/2008 | CA2683452A1 Use of an anti-cxcr4 antibody for treating cancer |
| 11/27/2008 | CA2680661A1 Mutant reoviruses and methods of making and using |
| 11/27/2008 | CA2654877A1 Stable elsamitrucin salts suitable for pharmaceutical formulations |
| 11/26/2008 | EP1995256A1 EPHA2 T-cell epitope agonists and uses therefor |
| 11/26/2008 | EP1995249A1 Camptothecin derivatives and their use |
| 11/26/2008 | EP1995238A2 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (GPCRS) |
| 11/26/2008 | EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 11/26/2008 | EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 11/26/2008 | EP1994044A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID |
| 11/26/2008 | EP1994033A1 Indolopyridines as eg5 kinesin modulators |
| 11/26/2008 | EP1994030A1 Multi-cyclic compounds and method of use |
| 11/26/2008 | EP1994028A1 Quinoline derivatives for treating cancer |
| 11/26/2008 | EP1994023A1 Quinazoline derivatives |
| 11/26/2008 | EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them . |
| 11/26/2008 | EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 11/26/2008 | EP1994000A2 Water-soluble cc-1065 analogs and their conjugates |
| 11/26/2008 | EP1993999A1 Improved prodrugs of cc-1065 analogs |
| 11/26/2008 | EP1993595A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 11/26/2008 | EP1993558A2 Oxysterol compounds and the hedgehog pathway |
| 11/26/2008 | EP1993553A1 Methods for cancer therapy and stem cell modulation |
| 11/26/2008 | EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 11/26/2008 | EP1515736B1 Compositions against inflammatory processes |
| 11/26/2008 | EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES |
| 11/26/2008 | EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 11/26/2008 | EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 11/26/2008 | EP1414455B1 Isoquinoline inhibitors of p38 |
| 11/26/2008 | EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 11/26/2008 | EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases |
| 11/26/2008 | EP1328267B1 Method of treating cancer using dithiocarbamate derivatives |
| 11/26/2008 | EP1299110B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites |
| 11/26/2008 | EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 11/26/2008 | CN101313219A A method of diagnosis and treatment and agents useful for same |
| 11/26/2008 | CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen |
| 11/26/2008 | CN101313061A Method of expanding double negative t cells |
| 11/26/2008 | CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer |
| 11/26/2008 | CN101312986A Method of producing a modified (poly)peptide |
| 11/26/2008 | CN101312970A 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 11/26/2008 | CN101312960A F,G,H,I and K crystal forms of imatinib mesylate |
| 11/26/2008 | CN101312958A 3, 6-dihydro-2-oxo-6H-(1,3,4)thiadiazine derivatives |
| 11/26/2008 | CN101312956A Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazines |
| 11/26/2008 | CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 11/26/2008 | CN101312737A Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 11/26/2008 | CN101312722A Modulators of atp-binding cassette transporters |
| 11/26/2008 | CN101311270A Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof |
| 11/26/2008 | CN101311193A Complexes using recombined triple helix support as base |
| 11/26/2008 | CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof |
| 11/26/2008 | CN101311188A Small molecule peptides inhibitor of human heparinase |
| 11/26/2008 | CN101311187A Tripterine derivate, preparation method and use thereof |
| 11/26/2008 | CN101311174A Vitamin B6 derivates and pharmaceutical use thereof |
| 11/26/2008 | CN101311173A Herpe-lactone, preparation method and use thereof |
| 11/26/2008 | CN101311166A Tyrosine kinase restraining agent, preparation method thereof and use |
| 11/26/2008 | CN101310770A Antibodies against cancer |
| 11/26/2008 | CN101310768A Medicine composition for treating hepatic disease and use thereof |
| 11/26/2008 | CN101310767A Cryosurgery anticancer antigen preparation and preparation method thereof |
| 11/26/2008 | CN101310753A Analgesic and anticancer plaster and preparation method thereof |
| 11/26/2008 | CN101310742A Tibetan medicine Honglian extract and use thereof |